Cancer Center

Cancer Center

Phone Numbers

Hematology / Oncology
(803) 794-7511
Radiation Oncology
(803) 791-2575
Women's Imaging
(803) 791-2486

Gastrointestinal Cancer

Our Gastrointestinal Cancer Program

  • Less painful, more effective chemotherapy treatment.
  • More than 400 cases treated in 2014.
  • Microwave ablation of certain tumors available.

Many types of gastrointestinal cancer grow slowly and are possible to treat early.

Treating Gastrointestinal Cancer

Most gastrointestinal cancer is treated with surgery, which may be combined with chemotherapy and radiation. Your doctor will discuss options with you, and decide what's best for your individual diagnosis.

Nurse Navigators

A nurse navigator will work with you through the whole treatment process. She'll help you understand your diagnosis, take care of scheduling, and coordinate with doctors to get you the answers and help you need.

Supportive Care

Our care is comprehensive, with support for your personal challenges that goes beyond the disease.

Just a few ways we help:

New Treatments

Our affiliation with the MUSC Hollings Cancer Center gives patients access to more than 200 clinical trials and a wide range of the most promising cancer treatments currently available.

Less Painful Chemotherapy Infusion
Our advanced pain-reducing chemotherapy allows for longer rounds of infusion into the tumor.

Research Trials

We offer qualifying patients access to the latest clinical trials.

Enroll in a Clinical Trial

(803) 935-8300

A022104 The Janus Rectal Cancer Trial

Description
A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.

Testing the addition of an anti-cancer drug, irinotecan, to the standard chemotherapy treatment (FOLFOX) after long-course radiation therapy for advanced-stage rectal cancers to improve the rate of complete response and long-term rates of organ preservation and continuing response. 

Open to enrollment.

Posted By: Dr. James Wells

Posted Date: 4/24/2024

Location: Lexington Medical Cancer Center